TuHURA Biosciences (HURA) EPS (Diluted) (2012 - 2026)

TuHURA Biosciences (HURA) EPS (Diluted) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - 0.00
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 0.00
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 0.15
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 4.02
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 6.75
7 Belite Bio 62.72 Bn 62.72 Bn - 0.00
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 7.33
9 Revolution Medicines 37.35 Bn 37.35 Bn - -2.29
10 TuHURA Biosciences 132.62 Mn 132.62 Mn - -0.13

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.13
Dec 31, 2025 -0.14
Sep 30, 2025 -0.14
Jun 30, 2025 -0.21
Mar 31, 2025 -0.15
Sep 30, 2024 -1.37
Jun 30, 2024 -0.83
Mar 31, 2024 -0.51
Dec 31, 2023 -0.35
Sep 30, 2023 -5,766.54
Jun 30, 2023 8,573.53
Mar 31, 2023 -6,003.68
Dec 31, 2022 -6,352.94
Sep 30, 2022 -9,117.65
Jun 30, 2022 -3.68
Mar 31, 2022 -9,849.26
Dec 31, 2021 -10,836.40
Sep 30, 2021 -15,496.32
Jun 30, 2021 -12,382.35
Mar 31, 2021 -12,211.40